- Arena Pharmaceuticals, Inc.
$353 Million - Follow-OnJoint Bookrunner
- Xencor, Inc.
$226 Million - Follow-OnJoint Bookrunner
- Arcus Biosciences
$120 Million - Initial Public OfferingJoint Bookrunner
- A / Site Visit Highlights Efforts to Drive Value to Customers and Gain Market Share / Outperform
- AGN / Looking for Migraine Relief; A Closer Look at AGN’s Oral CGRPs
- Healthcare / 2018 Outlook: Alpha Opportunities Abound in Healthcare Shares